World No Tobacco Day

May 31, 2021

Did you know that tobacco is the main risk factor for bladder cancer?

In 75% of cases, bladder cancer is non-invasive but 5-year progression (0.8% – 45%) and recurrence (31% – 78%) rates are high. Patients with this type of cancer must therefore undergo regular examinations to enable early treatment.

Several urinary tests have been developed to overcome the drawbacks of reference examination methods;  in particular the invasive nature of cystoscopy, and the problems of sensitivity and of intra- and inter-observer reproducibility associated with cytology.

The results of a recent study support the use of the Xpert Bladder Cancer Monitor test developed by Cepheid for the monitoring of these patients in clinical practice. We would like to thank Géraldine Cancel-Tassin, Morgan Rouprêt, Ugo Pinar, Cécile Gaffory, Félicien Vanié, Valérie Ondet, Eva Compérat, Olivier Cussenot, Myriam Livrozet, and Laura Fabre for entrusting our medical writing team with writing and English editing of this article!